Axsome Therapeutics Inc. (NASDAQ: AXSM) is -11.72% lower on its value in year-to-date trading and has touched a low of $20.63 and a high of $82.85 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The AXSM stock was last observed hovering at around $68.73 in the last trading session, with the day’s loss setting it -0.64% off its average median price target of $98.00 for the next 12 months. It is also 65.95% off the consensus price target high of $200.00 offered by 14 analysts, but current levels are -19.46% lower than the price target low of $57.00 for the same period.
Currently trading at $68.09, the stock is -8.87% and -1.05% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.88 million and changing -0.93% at the moment leaves the stock 8.15% off its SMA200. AXSM registered 161.38% gain for a year compared to 6-month gain of 18.98%. The firm has a 50-day simple moving average (SMA 50) of $23.06 and a 200-day simple moving average (SMA200) of -$23.71.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
The stock witnessed a -2.88% loss in the last 1 month and extending the period to 3 months gives it a 11.53%, and is -11.42% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.75% over the week and 4.48% over the month.
Axsome Therapeutics Inc. (AXSM) has around 383 employees, a market worth around $3.01B and $144.60M in sales. Distance from 52-week low is 230.05% and -17.82% from its 52-week high. The company has generated returns on investments over the last 12 months (-88.20%).
Axsome Therapeutics Inc. (AXSM) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Axsome Therapeutics Inc. (AXSM) is a “Overweight”. 14 analysts offering their recommendations for the stock have an average rating of 1.90, where 2 rate it as a Hold and 0 think it is a “Overweight”. 11 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Axsome Therapeutics Inc. is expected to release its quarterly report on 08/09/2023.The EPS is expected to shrink by -32.80% this year
Axsome Therapeutics Inc. (AXSM) Top Institutional Holders
The shares outstanding are 43.52M, and float is at 35.41M with Short Float at 21.66%.
Axsome Therapeutics Inc. (AXSM) Insider Activity
A total of 1 insider transactions have happened at Axsome Therapeutics Inc. (AXSM) in the last six months, with sales accounting for 0 and purchases happening 1 times.
Axsome Therapeutics Inc. (AXSM): Who are the competitors?
The company’s main competitors (and peers) include Pieris Pharmaceuticals Inc. (PIRS) that is trading -50.60% down over the past 12 months.